| |
| |
|
| Insider
Information: |
Poukalov Konstantin |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
21,082 |
|
|
Indirect Shares
|
14,869,915 |
|
|
| Direct
Value |
$38,000 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
14,890,997 |
|
|
| Total
Value |
$38,000 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kadmon Holdings, Llc |
KDMN |
EVP, Chief Financial O... |
2016-11-11 |
4,000 |
2016-11-11 |
0 |
Premium* |
|
|
Landos Biopharma, Inc. |
LABP |
Director, 10% Owner |
2021-02-08 |
0 |
2021-02-09 |
14,869,915 |
Premium* |
|
|
Lianbio |
LIAN |
Director |
2024-02-15 |
17,082 |
2024-02-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIAN |
Lianbio |
Director |
– • – |
2024-02-15 |
4 |
OE |
$2.52 |
$91,476 |
D/D |
36,300 |
36,300 |
0 |
- |
|
| LIAN |
Lianbio |
Director |
– • – |
2024-02-15 |
4 |
D |
$4.76 |
$91,478 |
D/D |
(19,218) |
17,082 |
0 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-09 |
4 |
B |
$13.80 |
$1,403,559 |
I/I |
99,681 |
14,869,915 |
2.25 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
I/I |
13,369,728 |
13,369,728 |
0 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
B |
$16.00 |
$20,000,000 |
I/I |
1,250,000 |
14,619,728 |
2.25 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-08 |
4 |
B |
$11.38 |
$1,503,061 |
I/I |
123,053 |
14,770,234 |
2.25 |
- |
|
| LABP |
Landos Biopharma, Inc. |
Director |
– • • |
2021-02-05 |
4 |
B |
$11.14 |
$305,826 |
I/I |
27,453 |
14,647,181 |
2.25 |
- |
|
| KDMN |
Kadmon Holdings, Llc |
EVP, Chief Financial Officer |
• – – |
2016-11-11 |
4 |
B |
$5.43 |
$23,250 |
D/D |
4,000 |
4,000 |
2.74 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
